Dublin, March 13, 2026 (GLOBE NEWSWIRE)-- The "Roferon-a Market Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts" has been added to ResearchAndMarkets.com's offering.
Dublin, March 10, 2026 (GLOBE NEWSWIRE) -- The "Infergen Market Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts" has been added to ResearchAndMarkets.com's offering. The ...
Dublin, March 10, 2026 (GLOBE NEWSWIRE) -- The "Extavia Market Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts" has been added to ResearchAndMarkets.com's offering. The ...
Kali Therapeutics, a clinical-stage biotechnology company pioneering next-generation immune-resetting therapies, today announced that dosing is underway for the first cohort of patients in its Phase ...
Early GO decision reached in CAPTIVATE ahead of Q2’26 guidance based on GO criteria of 20 confirmed responders achieved with less than 40 planned ...
Extended long-term survival observed after an additional year of follow-up in ongoing phase 2a clinical trial, with 50% of 46 patients with ...
Barclays 28th Annual Global Healthcare Conference March 12, 2026 9:30 AM EDTCompany ParticipantsBruce Jacobs - ...
Patients with RA who use abatacept mount little humoral or cell-mediated responses to the recombinant zoster vaccine, with more injection-site reactions but similar RA flare rates compared with ...
Slimming injections are booming, but how they work, their side effects, and actual weight loss vary. Here’s what you need to know. The past year has completely changed the way we view obesity. Whereas ...
Some patients taking popular GLP-1 weight loss drugs may be able to keep the weight off while taking injections less often, according to a small new study. The idea began when Dr. Mitch Biermann, an ...
The FDA has previously granted fast track designation to aglatimagene plus valacyclovir in combination with ICI therapy for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results